AIMC Topic: Prognosis

Clear Filters Showing 841 to 850 of 3837 articles

Bidirectional recurrent neural network approach for predicting cervical cancer recurrence and survival.

Scientific reports
Cervical cancer is a deadly disease in women globally. There is a greater chance of getting rid of cervical cancer in case of earliest diagnosis. But for some patients, there is a chance of recurrence. The chances of treating the Recurrence of cervic...

Predicting local control of brain metastases after stereotactic radiotherapy with clinical, radiomics and deep learning features.

Radiation oncology (London, England)
BACKGROUND AND PURPOSE: Timely identification of local failure after stereotactic radiotherapy for brain metastases allows for treatment modifications, potentially improving outcomes. While previous studies showed that adding radiomics or Deep Learni...

Integration of Optical Coherence Tomography Images and Real-Life Clinical Data for Deep Learning Modeling: A Unified Approach in Prognostication of Diabetic Macular Edema.

Journal of biophotonics
The primary ocular effect of diabetes is diabetic retinopathy (DR), which is associated with diabetic microangiopathy. Diabetic macular edema (DME) can cause vision loss for people with DR. For this reason, deciding on the appropriate treatment and f...

Machine learning-based prognostic modeling in gallbladder cancer using clinical data and pre-treatment [F]-FDG-PET-radiomic features.

Japanese journal of radiology
OBJECTIVES: This study evaluates the effectiveness of machine learning (ML) models that incorporate clinical and 2-deoxy-2-[F]fluoro-D-glucose ([F]-FDG)-positron emission tomography (PET)-radiomic features for predicting outcomes in gallbladder cance...

Identification of the shared gene signatures in retinoblastoma and osteosarcoma by machine learning.

Scientific reports
Osteosarcoma (OS) is the most prevalent secondary sarcoma associated with retinoblastoma (RB). However, the molecular mechanisms driving the interactions between these two diseases remain incompletely understood. This study aims to explore the transc...

Integrating immune multi-omics and machine learning to improve prognosis, immune landscape, and sensitivity to first- and second-line treatments for head and neck squamous cell carcinoma.

Scientific reports
In recent years, immune checkpoint inhibitors (ICIs) has emerged as a fundamental component of the standard treatment regimen for patients with head and neck squamous cell carcinoma (HNSCC). However, accurately predicting the treatment effectiveness ...

Multiomics integration and machine learning reveal prognostic programmed cell death signatures in gastric cancer.

Scientific reports
Gastric cancer (GC) is characterized by notable heterogeneity and the impact of molecular subtypes on treatment and prognosis. The role of programmed cell death (PCD) in cellular processes is critical, yet its specific function in GC is underexplored...

Predictive modelling of hospital-acquired infection in acute ischemic stroke using machine learning.

Scientific reports
Hospital-acquired infections (HAIs) are serious complication for patients with acute ischemic stroke (AIS), often resulting in poor functional outcomes. However, no existing model can specifically predict HAI in AIS patients. Therefore, we employed t...

A machine learning-based immune response signature to facilitate prognosis prediction in patients with endometrial cancer.

Scientific reports
Endometrial cancer is the most prevalent form of gynecologic malignancy, with a significant surge in incidence among youngsters. Although the advent of the immunotherapy era has profoundly improved patient outcomes, not all patients benefit from immu...

Prediction of Composite Clinical Outcomes for Childhood Neuroblastoma Using Multi-Omics Data and Machine Learning.

International journal of molecular sciences
Neuroblastoma is a common malignant tumor in childhood that seriously endangers the health and lives of children, making it essential to find effective prognostic markers to accurately predict their clinical outcomes. The development of high-throughp...